Paediatric rheumatology Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-α (cA2)

British Journal of Rheumatology

Volumn 36, Issue 5, 1997, Pages 589-593

  Elliott, M J ^a   Woo, P ^b   Charles, P ^a   Long Fox, A ^a   Woody, J N ^a,c,d   Maini, R N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c CENTOCOR INC   (United States)

^d ROCHE BIOSCIENCE   (United States)

Author keywords

Juvenile chronic arthritis; Monoclonal antibody; Tumour necrosis factor

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; IBUPROFEN; INFLIXIMAB; INTERLEUKIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADOLESCENT; ANOREXIA; ARTICLE; CASE REPORT; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; BLOOD; BODY TEMPERATURE; CHRONIC DISEASE; DOSE RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; IMMUNOLOGY; JOINT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE-PHASE REACTION; ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ARTHRITIS, JUVENILE RHEUMATOID; BLOOD SEDIMENTATION; BODY TEMPERATURE; C-REACTIVE PROTEIN; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEVER; HUMANS; IBUPROFEN; INFUSIONS, INTRAVENOUS; INTERLEUKIN-1; JOINTS; PREDNISOLONE; SERUM AMYLOID A PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031134017     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Levison JE, Wallace CA. Dismantling the pyramid. J Rheumatol 1992;19:6-10.
2. Woo PMM. Growth retardation and osteoporosis in juvenile chronic arthritis. Clin Exp Rheumatol 1994;12:887-90.
3. Green Schaller J. Aggressive treatment in childhood rheumatic diseases. Clin Exp Rheumatol 1994;12:897-105.
4. Woo P. Amyloidosis in children. Baillière's Clin Rheumatol 1994;8:691-7.
5. Prieur A-M. Chronic arthritis in children. Curr Opin Rheumatol 1994;6:513-7.
6. Giannini EH, Brewer Ej, Kuzmina N et al. Methotrexate in resistant juvenile rheumatoid arthritis. N Engl J Med 1992;326:1043-9.
7. Shaikov AV, Maximov AA, Speransky AI, Lovell DJ, Giannini EH, Solovyev SK. Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis - preliminary results of a longterm study. J Rheumatol 1992;19:612-6.
8. a antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 1995;144:195-223.
9. Knight DM, Trinh H, Le J et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 1993;30:1443-53.
10. Elliott MJ, Maini RN, Feldmann M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
11. Elliott MJ, Maini RN, Feldman M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
12. Elliott MJ, Maini RN, Feldmann M et al. Repeated therapy with monoclonal antibody to tumour necrosis factor γ (cA2) in patients with rheumatoid arthritis. Lancet 1994;344:1125-8.
13. Lepore L, Pennesi M, Saletta S, Perticaraari S, Presani G, Prodan M. Study of IL-2, 1L-6, IFNγ and β in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 1994;12:561-5.
14. Madson KL, Moore TL, Lawrence III JM, Osborn TG. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994;21:2359-63.
15. Eberhard BA, Laxer RM, Andersson U, Silverman ED. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol 1994;96:260-6.
16. Rooney M, David J, Symons J, Di Giovine F, Varsani H, Woo P. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454-60.
17. Mangge H, Kenzian H, Gallistl S et al. Serum cytokines in juvenile rheumatoid arthritis. Arthritis Rheum 1995;38:211-20.
18. Gattorno M, Picco P, Buoncompagni A et al. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. Ann Rheum Dis 1996;55:243-7.
19. Howe S, Levinson J, Shear E et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. Arthritis Rheum 1991;34:873-80.
20. Karunaweer ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992;89:3200-3.
21. Kwiatkowski D, Molyneux ME, Stephens S et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 1993;86:91-8.
22. Ostrov BE. Nutrition and pediatric rheumatic diseases. Hypothesis: cytokines modulate nutritional abnormalities in rheumatic diseases. J Rheumatol 1992;19(suppl. 33):49-53.
23. De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991; 34:1158-63.
24. De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol 1992;10:493-8.
25. De Benedetti G, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9.
26. Oen K, Danell G. Interleukin 6 and autoantibodies in juvenile rheumatoid arthritis. J Rheumatol 1993; 20:1949-56.